Adrenal Support Complex
Natural health product licensed in Canada
- Licence holder
- Forbes Group
- NPN or DIN-HM
- 80065535
- Status
- Active licence
- Licence date
- 26 November 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 500 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Vitamine C | 125 milligramme | 500,000 µg |
| Glycyrrhiza glabra Source : Glycyrrhiza glabra - racine Extraction ratio : 5:1 Dry plant equivalent : 1,000 milligramme Potency : 10 % Glycyrrhizin | 200 milligramme | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Extraction ratio : 12:1 Dry plant equivalent : 600 milligramme Potency : 5 % Withanolides | 50 milligramme | Not calculated |
| Rhodiola rosea Source : Racine Extraction ratio : 8:1 Dry plant equivalent : 300 milligramme Potency : 1 % Salidroside | 37.5 milligramme | Not calculated |
| Panax ginseng Source : Panax ginseng - racine Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels and to help support cognitive function and/or reduce mental fatigue (in cases of mental stress) and enhance physical capacity/performance (in cases of physical stress). Used in Herbal Medicine (as an adaptogen) to help to temporary relieve symptoms of stress (such as mental fatigue and sensation of weakness) and to support cognitive function (such as mental focus and mental stamina). Provides antioxidants. Helps the body to metabolize carbohydrates, fats and proteins. Helps in connective tissue formation. An antioxidant for the maintenance of good health. Ashwagandha is traditionally used in Ayurveda as rejuvenative tonic, nervine tonic, sedative and sleep aid, to relieve general debility, especially during convalescence or old age and for memory enhancement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80065535
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.